Medical imaging has revealed that COVID-19 can in some cases “cause the body to attack itself,” marking the first glimpse at what is behind mysterious.
Mom s Heart Health Affects Child s for Years newsmax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmax.com Daily Mail and Mail on Sunday newspapers.
Maternal cardiovascular health in pregnancy associated with child s heart health in adolescence
A mother s heart health while she is pregnant may have a significant impact on her child s cardiovascular health in early adolescence (ages 10 to 14), according to a new study from Northwestern Medicine and the Ann & Robert H. Lurie Children s Hospital of Chicago.
The study will be published Feb. 16 in the
Journal of the American Medical Association (JAMA). It is the first study to examine the implications of a mother s cardiovascular health during pregnancy for offspring health in the longer term.
The findings are troubling, as they build upon previous Northwestern Medicine and Lurie Children s Hospital research that found more than 90% of U.S. mothers have suboptimal cardiovascular health levels during pregnancy.
Published: Feb 17, 2021
Thought leader in the ENT treatment community brings insight from clinical practice to next stage of development for LYR-210 and pipeline
WATERTOWN, Mass. (BUSINESS WIRE) Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases, today announced that Robert Kern, MD has been named Chief Medical Officer. He will also remain in his current position as the George A. Sisson Professor and Chair, Department of Otolaryngology – Head and Neck Surgery, Northwestern University Feinberg School of Medicine. Dr. Kern is the immediate past president of the
Scientists from the Stanley Manne Children s Research Institute at Ann & Robert H. Lurie Children s Hospital of Chicago demonstrated that a nanotherapy reduces intestinal inflammation and shrinks lesions in a rodent model of severe Crohn s disease.